Abstract: An example method of monitoring and measuring the line width of interconnects comprising the following steps. First, we measure an I-V profile of a sample interconnect structure to obtain a sample I-V profile. The I-V profile is comprised of leakage current measurements at two or more voltages. The sample interconnect structure is comprised of spaced lines having a line spacing. Next we compare the sample I-V profile with a reference I-V profile at a reference line spacing to determine if sample interconnect structure is not defective. If the sample I-V profile is similar to the reference I-V profile, then leakage currents for the sample interconnect structure are derived from the I-V profiles at a selected voltages. Then we calculate the line spacing of the sample interconnect structure using the sample I-V profile.

Abstract: The invention relates to a low power module, and in particular, to a low power module applied in a station of a wireless communication system. A low power module includes a first MAC module, a second MAC module, a low power switch register, a control register unit, a slow clock generator, and a multiplexer (MUX) The first and second MAC module transmits and receives packets in a normal operational mode and a power save mode, respectively. The low power switch register switches a current mode to another mode. The control register unit controls the RF/BB module and the clock generator under the control of the low power switch register. The slow clock generator generates a slow operational clock for the second MAC module in the power save mode. The MUX chooses the normal operational or the slow operational clock periodically as a clock of the second MAC module according to the control register unit.

Abstract: The present invention relates generally to the identification of the products of gene expression in cancerous tissue or other tissue associated with an aberrant medical condition. Identification of such expression products enables the development of a range of diagnostic and therapeutic agents. In one embodiment of the present invention, a gene is differentially or preferentially expressed in cancerous tissue relative to normal tissue. Identification of the expression product of the gene and of the gene itself provides a means of developing diagnostic and therapeutic agents for the treatment, prophylaxis, and diagnosis of the cancerous condition in which the gene is differentially or preferentially expressed.

Abstract: An illuminated sign having front, back and side surfaces. A plurality of first cavities are formed into the back surface of the sign. A plurality of light emitting modules are disposed in the plurality of first cavities. The modules each include a light emitting diode having an emission axis and for producing at least some light output generally parallel to the emission axis, an optical device disposed adjacent the light source having a reflective surface for reflecting the light output in directions that are generally perpendicular to the emission axis, and a guide element disposed adjacent the optical device for coupling the reflected light output into the interior of the sign. The guide element includes a second cavity formed therein in which the optical device is disposed. The front surface is illuminated by the coupled light output from the light emitting modules by reflection and/or diffusion inside the sign.